Pfizer announced today the initiation of a large, global Phase III clinical trial to evaluate the efficacy and safety of sunitinib malate, in combination with erlotinib, in previously treated patients with advanced non-small cell ...
From: www.finanzen.net
Pfizer Oncology Initiates Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib in Advanced ...
Posted by Ruslan Abuzant at 10:57 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment